MediaPharma srl の製品パイプライン分析2016

【英語タイトル】MediaPharma srl - Product Pipeline Review - 2016

Global Markets Directが出版した調査資料(DATA70209138)・商品コード:DATA70209138
・発行会社(調査会社):Global Markets Direct
Single UserUSD1,500 ⇒換算¥166,500見積依頼/購入/質問フォーム
Site LicenseUSD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprisewide (Global Site License)USD4,500 ⇒換算¥499,500見積依頼/購入/質問フォーム

MediaPharma srl – Product Pipeline Review – 2016

Global Markets Direct’s, ‘MediaPharma srl – Product Pipeline Review – 2016’, provides an overview of the MediaPharma srl’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by MediaPharma srl, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


- The report provides a snapshot of the pipeline therapeutic landscape of MediaPharma srl
- The report provides overview of MediaPharma srl including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses MediaPharma srl’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features MediaPharma srl’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate MediaPharma srl’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for MediaPharma srl
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding MediaPharma srl’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
MediaPharma srl Snapshot 5
MediaPharma srl Overview 5
Key Facts 5
MediaPharma srl – Research and Development Overview 6
Key Therapeutic Areas 6
MediaPharma srl – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
MediaPharma srl – Pipeline Products Glance 11
MediaPharma srl – Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
MediaPharma srl – Drug Profiles 12
MP-1959 – Drug Profile 12
Product Description 12
Mechanism Of Action 12
R&D Progress 12
MP-3546 – Drug Profile 13
Product Description 13
Mechanism Of Action 13
R&D Progress 13
MPBF-001 – Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
MPE-8.3 – Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
MPE-831959 – Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
MPEV-20 – Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
MPEV-20RT – Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
MediaPharma srl – Pipeline Analysis 19
MediaPharma srl – Pipeline Products by Target 19
MediaPharma srl – Pipeline Products by Molecule Type 20
MediaPharma srl – Pipeline Products by Mechanism of Action 21
MediaPharma srl – Dormant Projects 22
MediaPharma srl – Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 24
Disclaimer 25

List of Tables
MediaPharma srl, Key Facts 5
MediaPharma srl - Pipeline by Indication, 2016 7
MediaPharma srl - Pipeline by Stage of Development, 2016 9
MediaPharma srl - Monotherapy Products in Pipeline, 2016 10
MediaPharma srl - Preclinical, 2016 11
MediaPharma srl - Pipeline by Target, 2016 19
MediaPharma srl - Pipeline by Molecule Type, 2016 20
MediaPharma srl - Pipeline Products by Mechanism of Action, 2016 21
MediaPharma srl - Dormant Developmental Projects,2016 22

List of Figures
MediaPharma srl - Pipeline by Top 10 Indication, 2016 7
MediaPharma srl - Pipeline by Target, 2016 19
MediaPharma srl - Pipeline by Molecule Type, 2016 20
MediaPharma srl - Pipeline Products by Mechanism of Action, 2016 21

★調査レポート[MediaPharma srl の製品パイプライン分析2016] (コード:DATA70209138)販売に関する免責事項を必ずご確認ください。
★調査レポート[MediaPharma srl の製品パイプライン分析2016]についてメールでお問い合わせ